Skip to search formSkip to main contentSkip to account menu

Ribonuclease Inhibitor

Known as: Ribonuclease/Angiogenin Inhibitor 1, PRI, RAI 
Ribonuclease inhibitor (461 aa, ~50 kDa) is encoded by the human RNH1 gene. This protein plays a role in the inhibition of ribonucleases.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
The overall prognosis in pediatric differentiated thyroid carcinoma (DTC) is excellent. Recurrent disease is frequent, however… 
Highly Cited
2006
Highly Cited
2006
UNLABELLED Although 131I-iodine (RAI) therapy is a mainstay in the treatment of metastatic thyroid cancer, there is controversy… 
Highly Cited
2003
Highly Cited
2003
UNLABELLED This study is a retrospective analysis of 124 differentiated thyroid cancer patients who underwent dosimetric… 
Highly Cited
2002
Highly Cited
2002
ABSTRACT Rai is a recently identified member of the family of Shc-like proteins, which are cytoplasmic signal transducers… 
Review
2002
Review
2002
BACKGROUND First described 9 decades ago by H. S. Plummer, thyroidectomy and radioiodine remain the 2 therapeutic modalities for… 
Highly Cited
1991
Highly Cited
1991
The interactions of human placental ribonuclease inhibitor (PRI) with bovine pancreatic ribonuclease (RNase) A and human… 
Highly Cited
1980
Highly Cited
1980
A patient with T-cell chronic lymphocytic leukemia (T-CLL) is reported whose cells demonstrate in vitro suppression of normal…